重磅产品获批临床!500亿过敏性鼻炎用药市场将迎变局

制药网
Mar 11

过敏性鼻炎是一种由IgE介导的鼻腔黏膜炎症反应,临床表现为鼻塞、流涕、喷嚏、鼻痒等症状。在高频复发且患者规模庞大等特征下,过敏性鼻炎催生了百亿元规模的药物市场。有数据显示,2024年—2028年,我国过敏性鼻炎用药行业市场规模由432.75亿元增长至500.9亿元。面对这一广阔的市场,国内药企也在积极加码研发。近日,长风药业便公告称,公司自主研发的奥洛他定莫米松鼻喷雾剂获得国家药品监督管理局...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10